Emmanuelle Clappier

1. Determinants of CD19-positive vs CD19-negative relapse after tisagenlecleucel for B-cell acute lymphoblastic leukemia
   2021/05/17 by Marie-Emilie Dourthe, Marie-Émilie Dourthe, Florence Rabian +34 · 4 citations
   Medicine · Biochemistry, Genetics and Molecular Biology · #CAR-T cell therapy research #Acute Lymphoblastic Leukemia research #Virus-based gene therapy research
2. An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions
   2013/09/25 by Emmanuelle Clappier, E Clappier, Auclerc Mf +44 · 2 citations
   Medicine · #Acute Lymphoblastic Leukemia research #Childhood Cancer Survivors' Quality of Life #Chronic Myeloid Leukemia Treatments